 Bahram Salmanian
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta Accreta | 17 | 2023 | 22 | 7.370 |
Why?
| | Placenta Previa | 7 | 2022 | 9 | 2.370 |
Why?
| | Cesarean Section | 16 | 2023 | 165 | 2.170 |
Why?
| | Hysterectomy | 11 | 2022 | 117 | 1.500 |
Why?
| | Pregnancy | 38 | 2023 | 5667 | 1.170 |
Why?
| | Fertilization in Vitro | 3 | 2021 | 73 | 1.090 |
Why?
| | Fetal Diseases | 4 | 2015 | 148 | 0.790 |
Why?
| | Blood Transfusion | 3 | 2023 | 278 | 0.730 |
Why?
| | Placenta | 8 | 2023 | 637 | 0.520 |
Why?
| | Hydrothorax | 1 | 2014 | 3 | 0.480 |
Why?
| | Cardiac Tamponade | 1 | 2014 | 16 | 0.480 |
Why?
| | Fetofetal Transfusion | 3 | 2022 | 23 | 0.460 |
Why?
| | Pre-Eclampsia | 3 | 2023 | 183 | 0.460 |
Why?
| | Retrospective Studies | 20 | 2023 | 12922 | 0.450 |
Why?
| | Female | 41 | 2023 | 61147 | 0.440 |
Why?
| | Postpartum Hemorrhage | 3 | 2023 | 15 | 0.440 |
Why?
| | Blood Component Transfusion | 3 | 2021 | 69 | 0.420 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 189 | 0.390 |
Why?
| | Ultrasonography, Prenatal | 6 | 2019 | 227 | 0.370 |
Why?
| | Pregnancy Outcome | 8 | 2022 | 350 | 0.320 |
Why?
| | Humans | 41 | 2023 | 118066 | 0.300 |
Why?
| | Blood Loss, Surgical | 4 | 2019 | 87 | 0.270 |
Why?
| | Astigmatism | 2 | 2016 | 10 | 0.270 |
Why?
| | Sterilization, Tubal | 2 | 2015 | 10 | 0.260 |
Why?
| | Photorefractive Keratectomy | 2 | 2016 | 13 | 0.260 |
Why?
| | Myopia | 2 | 2016 | 37 | 0.260 |
Why?
| | Social Justice | 2 | 2015 | 63 | 0.250 |
Why?
| | Laser Therapy | 2 | 2015 | 104 | 0.240 |
Why?
| | Nuchal Translucency Measurement | 2 | 2013 | 2 | 0.230 |
Why?
| | Delivery, Obstetric | 2 | 2016 | 125 | 0.220 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2023 | 46 | 0.220 |
Why?
| | Adult | 21 | 2021 | 31230 | 0.220 |
Why?
| | Cohort Studies | 7 | 2022 | 5072 | 0.210 |
Why?
| | Chorioamnionitis | 1 | 2022 | 37 | 0.210 |
Why?
| | Prenatal Diagnosis | 2 | 2021 | 167 | 0.210 |
Why?
| | Erythrocyte Transfusion | 3 | 2019 | 183 | 0.210 |
Why?
| | Betamethasone | 2 | 2012 | 19 | 0.210 |
Why?
| | Obstetric Labor Complications | 1 | 2022 | 32 | 0.210 |
Why?
| | Apgar Score | 1 | 2021 | 16 | 0.200 |
Why?
| | Obstetric Labor, Premature | 2 | 2012 | 38 | 0.200 |
Why?
| | Gestational Age | 7 | 2022 | 765 | 0.200 |
Why?
| | Heart Rate, Fetal | 1 | 2021 | 22 | 0.200 |
Why?
| | Obstetrics | 1 | 2023 | 162 | 0.200 |
Why?
| | Urologic Diseases | 1 | 2021 | 36 | 0.200 |
Why?
| | Embryo Transfer | 1 | 2021 | 28 | 0.200 |
Why?
| | Umbilical Arteries | 1 | 2021 | 38 | 0.200 |
Why?
| | Labor, Obstetric | 1 | 2021 | 53 | 0.200 |
Why?
| | Anemia | 1 | 2022 | 145 | 0.190 |
Why?
| | Intraoperative Complications | 1 | 2021 | 133 | 0.180 |
Why?
| | Premature Birth | 2 | 2022 | 284 | 0.180 |
Why?
| | Infant, Newborn | 9 | 2022 | 5227 | 0.180 |
Why?
| | Patient Care Team | 3 | 2019 | 521 | 0.170 |
Why?
| | Hypocalcemia | 1 | 2019 | 30 | 0.170 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 78 | 0.170 |
Why?
| | Heart Defects, Congenital | 2 | 2017 | 700 | 0.170 |
Why?
| | Placenta, Retained | 2 | 2017 | 2 | 0.170 |
Why?
| | Fetoscopy | 2 | 2015 | 29 | 0.160 |
Why?
| | Placenta Diseases | 1 | 2018 | 14 | 0.160 |
Why?
| | Lasers, Excimer | 2 | 2016 | 21 | 0.160 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2017 | 33 | 0.150 |
Why?
| | Hydrops Fetalis | 1 | 2017 | 14 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2020 | 422 | 0.150 |
Why?
| | Odds Ratio | 1 | 2020 | 992 | 0.150 |
Why?
| | Hemorrhage | 1 | 2021 | 606 | 0.150 |
Why?
| | Infertility, Female | 1 | 2017 | 94 | 0.150 |
Why?
| | Risk Factors | 6 | 2020 | 8950 | 0.140 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1468 | 0.140 |
Why?
| | Vasa Previa | 1 | 2015 | 3 | 0.140 |
Why?
| | Interdisciplinary Communication | 1 | 2017 | 186 | 0.130 |
Why?
| | Lymphatic Abnormalities | 1 | 2015 | 18 | 0.130 |
Why?
| | Treatment Outcome | 7 | 2018 | 9311 | 0.130 |
Why?
| | Renal Veins | 1 | 2015 | 12 | 0.130 |
Why?
| | Whooping Cough | 1 | 2015 | 49 | 0.130 |
Why?
| | Birth Weight | 4 | 2022 | 463 | 0.130 |
Why?
| | Tachycardia, Supraventricular | 1 | 2015 | 40 | 0.130 |
Why?
| | Corneal Pachymetry | 1 | 2014 | 15 | 0.120 |
Why?
| | Young Adult | 7 | 2020 | 10707 | 0.120 |
Why?
| | Fetal Therapies | 1 | 2014 | 32 | 0.120 |
Why?
| | Hernia, Diaphragmatic | 1 | 2014 | 68 | 0.120 |
Why?
| | Cornea | 1 | 2014 | 116 | 0.110 |
Why?
| | Venous Thrombosis | 1 | 2015 | 145 | 0.110 |
Why?
| | Clinical Protocols | 1 | 2014 | 234 | 0.110 |
Why?
| | Thyroxine | 1 | 2013 | 60 | 0.110 |
Why?
| | Receptors, Opioid, mu | 1 | 2013 | 52 | 0.110 |
Why?
| | Placental Circulation | 1 | 2013 | 56 | 0.110 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 126 | 0.110 |
Why?
| | Cervix Uteri | 1 | 2012 | 47 | 0.110 |
Why?
| | Morphine | 1 | 2013 | 132 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 467 | 0.100 |
Why?
| | Uterine Cervical Diseases | 1 | 2011 | 6 | 0.100 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2015 | 295 | 0.100 |
Why?
| | Liver Diseases | 1 | 2014 | 282 | 0.100 |
Why?
| | Urinary Incontinence, Stress | 1 | 2010 | 14 | 0.100 |
Why?
| | Laparoscopy | 1 | 2015 | 417 | 0.090 |
Why?
| | United States | 3 | 2022 | 12477 | 0.090 |
Why?
| | Pregnancy Complications | 2 | 2013 | 447 | 0.090 |
Why?
| | Laser Coagulation | 2 | 2022 | 55 | 0.090 |
Why?
| | Fetal Growth Retardation | 1 | 2014 | 468 | 0.090 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 436 | 0.090 |
Why?
| | Porphyrins | 1 | 2008 | 17 | 0.080 |
Why?
| | Fullerenes | 1 | 2008 | 17 | 0.080 |
Why?
| | Magnetics | 1 | 2008 | 37 | 0.080 |
Why?
| | Postoperative Complications | 1 | 2019 | 2230 | 0.080 |
Why?
| | Magnesium | 1 | 2008 | 150 | 0.080 |
Why?
| | Nitric Oxide | 1 | 2013 | 892 | 0.080 |
Why?
| | Maternal Age | 2 | 2017 | 121 | 0.070 |
Why?
| | Cytokines | 2 | 2012 | 1879 | 0.070 |
Why?
| | Adenosine Triphosphate | 1 | 2008 | 438 | 0.070 |
Why?
| | Pregnancy, Twin | 2 | 2016 | 22 | 0.070 |
Why?
| | Iran | 2 | 2016 | 36 | 0.060 |
Why?
| | Nanoparticles | 1 | 2008 | 324 | 0.060 |
Why?
| | Placentation | 2 | 2015 | 42 | 0.060 |
Why?
| | Pregnancy Trimester, Second | 2 | 2014 | 70 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1783 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3670 | 0.060 |
Why?
| | Myocardium | 1 | 2008 | 965 | 0.060 |
Why?
| | Child | 1 | 2022 | 19029 | 0.050 |
Why?
| | Cardiotocography | 1 | 2021 | 3 | 0.050 |
Why?
| | Blood Gas Analysis | 1 | 2021 | 69 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2017 | 4518 | 0.050 |
Why?
| | Incidence | 2 | 2022 | 2413 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2019 | 3142 | 0.050 |
Why?
| | Pregnant Women | 1 | 2022 | 132 | 0.050 |
Why?
| | Acidosis | 1 | 2021 | 84 | 0.050 |
Why?
| | Inflammation | 1 | 2011 | 2545 | 0.050 |
Why?
| | Iron | 1 | 2022 | 246 | 0.050 |
Why?
| | Family | 1 | 2023 | 569 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2019 | 29 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2019 | 59 | 0.040 |
Why?
| | Plasma | 1 | 2019 | 194 | 0.040 |
Why?
| | Perinatal Mortality | 1 | 2017 | 15 | 0.040 |
Why?
| | Isotonic Solutions | 1 | 2017 | 37 | 0.040 |
Why?
| | Breech Presentation | 1 | 2016 | 1 | 0.040 |
Why?
| | Refraction, Ocular | 1 | 2016 | 31 | 0.040 |
Why?
| | Emergencies | 1 | 2017 | 152 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2016 | 4571 | 0.030 |
Why?
| | Polyhydramnios | 1 | 2015 | 18 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 94 | 0.030 |
Why?
| | Fetal Death | 1 | 2014 | 53 | 0.030 |
Why?
| | Morbidity | 1 | 2015 | 293 | 0.030 |
Why?
| | Abortion, Eugenic | 1 | 2013 | 4 | 0.030 |
Why?
| | Karyotype | 1 | 2013 | 12 | 0.030 |
Why?
| | Thyroid Function Tests | 1 | 2013 | 11 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 2855 | 0.030 |
Why?
| | Twins, Monozygotic | 1 | 2014 | 216 | 0.030 |
Why?
| | Tomography, Optical Coherence | 1 | 2014 | 126 | 0.030 |
Why?
| | Prenatal Care | 1 | 2015 | 252 | 0.030 |
Why?
| | Thyrotropin | 1 | 2013 | 104 | 0.030 |
Why?
| | Nitrates | 1 | 2013 | 77 | 0.030 |
Why?
| | Nitrites | 1 | 2013 | 80 | 0.030 |
Why?
| | Hypothyroidism | 1 | 2013 | 68 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1894 | 0.030 |
Why?
| | Prospective Studies | 2 | 2016 | 6443 | 0.030 |
Why?
| | Rats | 2 | 2013 | 5329 | 0.030 |
Why?
| | Nitric Oxide Synthase | 1 | 2013 | 226 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 586 | 0.030 |
Why?
| | Reference Values | 1 | 2013 | 764 | 0.030 |
Why?
| | Narcotic Antagonists | 1 | 2013 | 136 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 714 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2652 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3421 | 0.020 |
Why?
| | Middle Aged | 3 | 2017 | 27434 | 0.020 |
Why?
| | Renal Insufficiency | 1 | 2013 | 150 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 200 | 0.020 |
Why?
| | Parity | 1 | 2010 | 100 | 0.020 |
Why?
| | Fetal Development | 1 | 2013 | 250 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1027 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 861 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 497 | 0.020 |
Why?
| | Interleukins | 1 | 2011 | 242 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 812 | 0.020 |
Why?
| | Neutron Diffraction | 1 | 2008 | 3 | 0.020 |
Why?
| | Scattering, Small Angle | 1 | 2008 | 20 | 0.020 |
Why?
| | Isotopes | 1 | 2008 | 26 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 623 | 0.020 |
Why?
| | Postpartum Period | 1 | 2010 | 268 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2008 | 138 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2008 | 118 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2431 | 0.020 |
Why?
| | Drug Discovery | 1 | 2008 | 123 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2008 | 395 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2008 | 526 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2011 | 1679 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1159 | 0.020 |
Why?
| | Male | 3 | 2022 | 57376 | 0.020 |
Why?
| | Kidney | 1 | 2013 | 1351 | 0.020 |
Why?
| | Heart | 1 | 2008 | 630 | 0.020 |
Why?
| | Time Factors | 1 | 2015 | 6362 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3160 | 0.010 |
Why?
| | Oxygen | 1 | 2008 | 849 | 0.010 |
Why?
| | Adolescent | 2 | 2012 | 18342 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 785 | 0.010 |
Why?
| | Hypoxia | 1 | 2008 | 957 | 0.010 |
Why?
| | Animals | 2 | 2013 | 33107 | 0.010 |
Why?
|
|
Salmanian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|